<DOC>
	<DOC>NCT01570894</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Roxane Laboratories' Quetiapine Fumarate 25 mg Tablet under fed conditions.</brief_summary>
	<brief_title>Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to quetiapine or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>